Cargando…
Metabolic Profiling Identified a Novel Biomarker Panel for Metabolic Syndrome-Positive Hepatocellular Cancer
Metabolic syndrome (MetS) is an independent risk factor for hepatocellular cancer (HCC). Currently, there is no highly sensitive and specific biomarkers for HCC surveillance in MetS population. Metabolomics has been reported as a powerful technology for biomarker discovery. In the present study, we...
Autores principales: | Cao, Lin-Lin, Han, Yi, Wang, Yuanxiao, Pei, Lin, Yue, Zhihong, Qin, Li, Liu, Boyu, Cui, Jingwen, Jia, Mei, Wang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826723/ https://www.ncbi.nlm.nih.gov/pubmed/35154012 http://dx.doi.org/10.3389/fendo.2021.816748 |
Ejemplares similares
-
The Potential of Serum Exosomal hsa_circ_0028861 as the Novel Diagnostic Biomarker of HBV-Derived Hepatocellular Cancer
por: Wang, Yuanxiao, et al.
Publicado: (2021) -
Hypoglycaemia Metabolic Gene Panel Testing
por: Maiorana, Arianna, et al.
Publicado: (2022) -
Metabolic Characteristics and M2 Macrophage Infiltrates in Invasive Nonfunctioning Pituitary Adenomas
por: Lin, Kunzhe, et al.
Publicado: (2022) -
PPARα: An emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases
por: Lin, Yijun, et al.
Publicado: (2022) -
Association between abnormal lipid metabolism and tumor
por: Li, Chunyu, et al.
Publicado: (2023)